Economics
4.9
How companies measure patient well-being is about to get serious scrutiny
A new scoping review examines how the visual analogue scale—a simple tool where patients rate their health on a line from 0 to 100—is being used in clinical research and real-world healthcare decisions. The finding matters because these measurements increasingly drive pharmaceutical approvals, insurance coverage decisions, and treatment pricing across major markets.
Originaltitel: Use of the visual analogue scale for health state valuation: a scoping review